Phathom Pharmaceuticals PHAT

$ 7.45 -4.73%

Quarterly report 2024-Q3
added 11-07-2024

Phathom Pharmaceuticals Financial Statements 2011-2024 | PHAT

Annual Financial Statements Phathom Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	471 M	342 M	728 M	1.31 B	397 M	-	-	-	-	-	-	-	-
Shares	51.3 M	39.1 M	37 M	34.1 M	11.4 M	-	-	-	-	-	-	-	-
Historical Prices	9.19	8.74	19.7	33.2	31.1	-	-	-	-	-	-	-	-
Net Income	-202 M	-198 M	-144 M	-129 M	-255 M	-1.29 M	-	-	-	-	-	-	-
Revenue	682 K	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	167 K	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	515 K	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-167 M	-172 M	-135 M	-126 M	-106 M	-1.22 M	-	-	-	-	-	-	-
Interest Expense	42 M	27.3 M	6.79 M	4.58 M	4.18 M	13 K	-	-	-	-	-	-	-
EBITDA	-167 M	-172 M	-135 M	-125 M	-106 M	-1.28 M	-	-	-	-	-	-	-
Operating Expenses	168 M	172 M	135 M	126 M	106 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	118 M	101 M	62.7 M	27.5 M	6.94 M	1.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Phathom Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	64.6 M	58.6 M	58 M	56.8 M	48.5 M	42.4 M	41.5 M	38.8 M	38.3 M	38 M	30.5 M	37.3 M	36.6 M	36.3 M	34.1 M	33.4 M	33 M	32.5 M	24.7 M	7.33 M	6.69 M	6.59 M	6.76 M	6.76 M	6.76 M	3.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-85.6 M	-91.4 M	-	-43.2 M	-41 M	-37.8 M	-	-51.1 M	-50.9 M	-40.7 M	-	-36.7 M	-36.6 M	-34.8 M	-53.7 M	-34.1 M	-21.1 M	-20.1 M	-98 M	-68.1 M	-87.8 M	-1.25 M	-484 K	-290 K	-260 K	-254 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	16.4 M	7.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	2.36 M	1.38 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	14 M	5.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-70.8 M	-77.3 M	-	-35.7 M	-31.7 M	-30.1 M	-	-42.5 M	-45.4 M	-37.9 M	-	-33.1 M	-35.3 M	-33.6 M	-52.4 M	-32.8 M	-20 M	-20.4 M	-15.7 M	-6.28 M	-83 M	-1.23 M	-451 K	-268 K	-255 K	-251 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-8 K	17.8 M	-	-197 K	9.62 M	9.22 M	-	9.28 M	5.67 M	2.76 M	-	1.48 M	1.26 M	1.27 M	-	1.29 M	1.26 M	738 K	-	1.99 M	1.14 M	11 K	-	4 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-70.6 M	-77.1 M	-	-35.6 M	-31.6 M	-29.9 M	-	-42.3 M	-45.3 M	-37.8 M	-	-32.8 M	-35.2 M	-33.5 M	-52.4 M	-32.6 M	-19.9 M	-20.3 M	-15.7 M	-6.28 M	-83 M	-1.23 M	-451 K	-268 K	-255 K	-251 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	84.8 M	83.2 M	-	35.7 M	31.7 M	30.1 M	-	42.5 M	45.4 M	37.9 M	-	33.1 M	35.3 M	33.6 M	52.4 M	32.8 M	20 M	20.4 M	15.7 M	6.28 M	83 M	1.23 M	451 K	268 K	255 K	251 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	76.1 M	75.9 M	-	23.4 M	18.9 M	18.6 M	-	23.5 M	26.5 M	20.2 M	-	16.5 M	13.7 M	13 M	10.8 M	7.06 M	5.16 M	4.51 M	2.99 M	1.81 M	1.34 M	797 K	437 K	262 K	255 K	251 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency